Shiwei Liu is a biologist with a research background in cell biology, genomics, microscopy-based biotechnologies, and gene therapy.
Prior to joining Jones Day in 2025, Shiwei conducted post-doctoral research in spatial genomics at Harvard University and completed his Ph.D. at Harvard Medical School/Harvard University, where his work examined the relationship between cancer cell division and genome instability. He also gained industry experience as a scientist at Qilu Pharmaceuticals, where he developed gene therapies for human diseases. He has authored several peer-reviewed publications in the fields of cancer, cell biology, and genomics.
- Harvard University (Ph.D. in Biological and Biomedical Sciences 2019); Fudan University (B.S. in Biological Sciences 2012)
- Registered to practice before the United States Patent and Trademark Office
Antes del envío, por favor tenga en cuenta:
la información contenida en www.jonesday.com es para uso general y no constituye asesoramiento legal. El envío y recepción de este correo electrónico no pretenden crear una relación abogado-cliente. La información que envíe a cualquier persona de nuestra Firma no tendrá carácter confidencial o privilegiado excepto en el caso de que estemos actúando en su representación. Si envía este correo electrónico, confirma que ha leído y comprendido este aviso.